Prognostic Value of Redox Status Biomarkers in Patients Presenting with STEMI or Non-STEMI: A Prospective

Zorica Savovic1, Bozidar Pindovic2, Maja Nikolic3

  • 1Department of Internal Medicine, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.

Insights

Oxidative stress markers like superoxide anion radicals and reduced glutathione, alongside troponin I and NT-pBNP, can predict ST-elevation myocardial infarction evolution in early patient evaluations.

Area of Science:

  • Cardiology
  • Biochemistry
  • Internal Medicine

Background:

  • Oxidative stress (OS) plays a role in myocardial infarction (MI).
  • Understanding redox balance is crucial for early MI evaluation.
  • Differentiating between ST-elevated myocardial infarction (STEMI) and non-ST-elevated myocardial infarction (NSTEMI) is important.

Purpose of the Study:

  • To determine the role of OS in the early evaluation of STEMI and NSTEMI patients.
  • To define the role of redox balance in profiling MI development.
  • To identify early predictors of ST evolution in MI.

Main Methods:

  • Prospective observational case-control study.
  • Inclusion of 40 STEMI and 39 NSTEMI patients.
  • Blood sample collection for cardio-specific enzymes, OS biomarkers, and antioxidant enzymes at admission and 12 hours post-admission.

Main Results:

  • Superoxide anion radicals were elevated in NSTEMI patients 6 hours post-admission.
  • Hydrogen peroxide levels were significantly increased in the NSTEMI group.
  • Positive correlation between superoxide anion radicals and troponin I; inverse correlation between reduced glutathione and NT-pBNP.

Conclusions:

  • Superoxide anion radicals and reduced glutathione, along with hs-troponin I and NT-pBNP, may predict ST evolution.
  • Redox balance markers are valuable in early MI assessment.
  • These biomarkers can aid in profiling MI development and patient stratification.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
201
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
10
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
119
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30